Back
Madrigal Pharmaceuticals 10K Form
Buy
57
MDGL
Madrigal Pharmaceuticals
Last Price:
322.77
Seasonality Move:
35.27%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MDGL News And Ratings
See the #1 stock for the next 7 days that we like better than MDGL
MDGL Financial Statistics
Sales & Book Value
| Annual Sales: | $150K |
|---|---|
| Cash Flow: | $-67.76M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $35.64 |
| Price / Book: | 8.52 |
Profitability
| EPS (TTM): | -25.12000 |
|---|---|
| Net Income (TTM): | $-518.67M |
| Gross Margin: | $0 |
| Return on Equity: | -89.04% |
| Return on Assets: | -62.74% |
Madrigal Pharmaceuticals Earnings Forecast
Key Madrigal Pharmaceuticals Financial Ratios
- The Selling, General & Administrative Expenses for MDGL have been equal to 7,786.67% of Gross Profit Margin.
- The Interest Expense is -3.40% of Operating Income.
- Per Share Earnings over the last 23 years have been positive in 8 years.
Madrigal Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MDGL |
| CUSIP: | 558868 |
| Website: | madrigalpharma.com |
Debt
| Debt-to-Equity Ratio: | 0.15 |
|---|---|
| Current Ratio: | 5.98 |
| Quick Ratio: | 5.79 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MDGL Technical Analysis vs Fundamental Analysis
Buy
57
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy or a Sell?
-
Madrigal Pharmaceuticals stock is rated a Buy
The current Madrigal Pharmaceuticals [MDGL] share price is $317.09. The Score for MDGL is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.